HomeCompareWMELF vs MRK

WMELF vs MRK: Dividend Comparison 2026

WMELF yields 33.25% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 WMELF wins by $128.7K in total portfolio value
10 years
WMELF
WMELF
● Live price
33.25%
Share price
$0.08
Annual div
$0.02
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$159.4K
Annual income
$23,047.77
Full WMELF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — WMELF vs MRK

📍 WMELF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodWMELFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, WMELF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
WMELF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WMELF
Annual income on $10K today (after 15% tax)
$2,826.38/yr
After 10yr DRIP, annual income (after tax)
$19,590.60/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, WMELF beats the other by $18,782.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WMELF + MRK for your $10,000?

WMELF: 50%MRK: 50%
100% MRK50/50100% WMELF
Portfolio after 10yr
$95.1K
Annual income
$11,999.04/yr
Blended yield
12.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

WMELF
No analyst data
Altman Z
76.4
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WMELF buys
0
MRK buys
0
No recent congressional trades found for WMELF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricWMELFMRK
Forward yield33.25%3.25%
Annual dividend / share$0.02$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$159.4K$30.7K
Annual income after 10y$23,047.77$950.29
Total dividends collected$113.0K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: WMELF vs MRK ($10,000, DRIP)

YearWMELF PortfolioWMELF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$14,025$3,325.15$11,192$351.54+$2.8KWMELF
2$19,365$4,358.48$12,524$392.70+$6.8KWMELF
3$26,345$5,624.32$14,015$438.65+$12.3KWMELF
4$35,340$7,150.93$15,682$489.96+$19.7KWMELF
5$46,779$8,964.94$17,547$547.23+$29.2KWMELF
6$61,144$11,090.33$19,632$611.16+$41.5KWMELF
7$78,972$13,547.60$21,963$682.53+$57.0KWMELF
8$100,853$16,352.95$24,571$762.18+$76.3KWMELF
9$127,430$19,517.69$27,486$851.08+$99.9KWMELF
10$159,398$23,047.77$30,745$950.29+$128.7KWMELF

WMELF vs MRK: Complete Analysis 2026

WMELFStock

Westmount Energy Limited is a venture capital firm specializing in seed capital to small medium sized companies. The firm invests in Guyana-Suriname Basin regions. Westmount Energy Limited was incorporated in October 1, 1992 and is based in Saint Helier, Jersey.

Full WMELF Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this WMELF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WMELF vs SCHDWMELF vs JEPIWMELF vs OWMELF vs KOWMELF vs MAINWMELF vs JNJWMELF vs ABBVWMELF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.